Event Brief
UPDATED May 21, 2026 at 4:02 PM ET
May 21, 2026 at 7:02 AM ET
Eli Lilly says retatrutide cut up to 30% body weight
By The BriefBrief
Eli Lilly said its retatrutide drug helped trial participants lose up to 30% of body weight in a late-stage study.
WHO: Eli Lilly
WHAT: Eli Lilly reported late-stage trial results for retatrutide showing weight loss up to 30% (about 85 pounds)
WHEN: May 21, 2026 at 6:45 AM ET
WHERE: Location not specified
WHY: Eli Lilly issued a news release about retatrutide’s late-stage clinical trial results.
Reporting from 4 identified publishers across this event arc.
View all 4 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Ortagus warns Trump on Iran nuclear talks stalling
Iran
May 21, 2026 at 7:02 AM ET
Teen takeover triggers arrests, assaults and curfew in Long Branch
Long Branch
May 21, 2026 at 7:02 AM ET
Meta begins new layoffs affecting about 10% of staff
Meta
May 21, 2026 at 7:02 AM ET
Trump approval dips in Tennessee as inflation rises
Poll
May 21, 2026 at 7:00 AM ET
Page 17884 of 21419
Same format. Every time.
Continue reading — sign in or create a free account with
